This master class is for sponsors or biotech professionals who want to become certified experts in hybrid and decentralised clinical trial (DCT) design.
By the end of the class, you'll be able to:
Plus, learn firsthand what Tufts CSDD's new report says about decreases in clinical trial cycle times, screen failure rates, and substantive protocol elements that help drive:
Join Medable's Vice President of DCT, Claire Marsden, and Senior Director of Business Development, Chris Tutill, for what will surely be an engaging and informative master class.
Learn from the No. 1 DCT provider in the industry!
Claire Marsden is a Vice President of DCT Solutions, CV/MET at Medable.
Chris Tutill is a Senior Director of Business Development at Medable.